Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32652
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMusubire, Abdu Kisekka-
dc.contributor.authorCheema, Sanjay-
dc.contributor.authorRay, Jason C-
dc.contributor.authorHutton, Elspeth J-
dc.contributor.authorMatharu, Manjit-
dc.date2023-
dc.date.accessioned2023-04-14T02:47:33Z-
dc.date.available2023-04-14T02:47:33Z-
dc.date.issued2023-04-04-
dc.identifier.citationThe Journal of Headache and Pain 2023-04-04; 24(1)en_US
dc.identifier.issn1129-2377-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32652-
dc.description.abstractThe role of inflammation and cytokines in the pathophysiology of primary headache disorders is uncertain. We performed a systematic review and meta-analysis to synthesise the results of studies comparing peripheral blood cytokine levels between patients with migraine, tension-type headache, cluster headache, or new daily persistent headache (NDPH), and healthy controls; and in migraine between the ictal and interictal stages. We searched PubMed/Medline and Embase from inception until July 2022. We included original research studies which measured unstimulated levels of any cytokines in peripheral blood using enzyme-linked immunosorbent assay or similar assay. We assessed risk of bias using the Newcastle-Ottawa Quality Assessment Scale. We used random effects meta-analysis with inverse variance weighted average to calculate standardised mean difference (SMD), 95% confidence intervals, and heterogeneity for each comparison. This study is registered with PROSPERO (registration number CRD42023393363). No funding was received for this study. Thirty-eight studies, including 1335 patients with migraine (32 studies), 302 with tension-type headache (nine studies), 42 with cluster headache (two studies), and 1225 healthy controls met inclusion criteria. Meta-analysis showed significantly higher interleukin (IL)-6 (SMD 1.07, 95% CI 0.40-1.73, p = 0.002), tumour necrosis factor (TNF)-α (SMD 0.61, 95% CI 0.14-1.09, p = 0.01), and IL-8 (SMD 1.56, 95% CI 0.03-3.09, p = 0.04), in patients with migraine compared to healthy controls, and significantly higher interleukin-1β (IL-1β) (SMD 0.34, 95% CI 0.06-0.62, p = 0.02) during the ictal phase of migraine compared to the interictal phase. Transforming growth factor (TGF)-β (SMD 0.52, 95% CI 0.18-0.86, p = 0.003) and TNF-α (SMD 0.64, 95% CI 0.33-0.96, p = 0.0001) were both higher in patients with tension-type headache than controls. The higher levels of the proinflammatory cytokines IL-6, IL-8 and TNF-α in migraine compared to controls, and IL-1β during the ictal stage, suggest a role for inflammation in the pathophysiology of migraine, however prospective studies are required to confirm causality and investigate the mechanisms for the increase in cytokine levels identified. Cytokines may also have a role in tension-type headache. Due a lack of data, no conclusions can be made regarding cluster headache or NDPH.en_US
dc.language.isoeng-
dc.subjectCytokineen_US
dc.subjectImmunologyen_US
dc.subjectMigraine disordersen_US
dc.subjectNeurogenic inflammationen_US
dc.subjectTension-type headacheen_US
dc.titleCytokines in primary headache disorders: a systematic review and meta-analysis.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleThe Journal of Headache and Painen_US
dc.identifier.affiliationUniversity College London (UCL) Queen Square Institute of Neurology, London, UK.;Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.;Kiruddu National Referral Hospital, Kampala, Uganda.en_US
dc.identifier.affiliationNeurologyen_US
dc.identifier.affiliationDepartment of Neurology, Alfred Health, Melbourne, Australia.;Department of Neuroscience, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Neurology, Alfred Health, Melbourne, Australia.;Department of Neuroscience, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationUniversity College London (UCL) Queen Square Institute of Neurology, London, UK.;The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.en_US
dc.identifier.doi10.1186/s10194-023-01572-7en_US
dc.type.contentTexten_US
dc.identifier.pubmedid37016284-
dc.description.volume24-
dc.description.issue1-
dc.description.startpage36-
local.name.researcherRay, Jason C
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptNeurology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Nov 8, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.